Francisella philomiragia Infection and Lethality in Mammalian Tissue Culture Cell Models, Galleria mellonella, and BALB/c Mice.
Propst. Crystal N CN; Pylypko. Stephanie L SL; Blower. Ryan J RJ; Ahmad. Saira S; Mansoor. Mohammad M; van Hoek. Monique L ML
Key Findings
- F. philomiragia infects macrophage, liver and lung cells but kills some immune cells after 24 h
- The bacteria are more resistant to the human peptide LL‑37 (and mouse mCRAMP) than related Francisella species
- It is lethal in Galleria mellonella (LD50 ≈ 1.8 × 10³) and BALB/c mice (LD50 ≈ 3.45 × 10³)
Practical Outcomes
- For most health‑optimizing enthusiasts, the findings have limited direct use. The resistance to LL‑37 suggests this peptide alone isn’t a reliable antimicrobial against this organism, and the study mainly offers a safe BSL‑2 model for researchers rather than actionable health protocols.
Summary
This study shows that the bacterium Francisella philomiragia can infect several human and mouse cell types, kills some immune cells, and is surprisingly resistant to the natural antimicrobial peptide LL‑37, which limits its usefulness as a defense. It also proves the bug is deadly in insect and mouse models, making it a handy, low‑risk lab model for studying Francisella infections.
Abstract
Francisella (F.) philomiragia is a Gram-negative bacterium with a preference for brackish environments that has been implicated in causing bacterial infections in near-drowning victims. The purpose of this study was to characterize the ability of F. philomiragia to infect cultured mammalian cells, a commonly used invertebrate model, and, finally, to characterize the ability of F. philomiragia to infect BALB/c mice via the pulmonary (intranasal) route of infection. This study shows that F. philomiragia infects J774A.1 murine macrophage cells, HepG2 cells and A549 human Type II alveolar epithelial cells. However, replication rates vary depending on strain at 24 h. F. philomiragia infection after 24 h was found to be cytotoxic in human U937 macrophage-like cells and J774A.1 cells. This is in contrast to the findings that F. philomiragia was non-cytotoxic to human hepatocellular carcinoma cells, HepG2 cells and A549 cells. Differential cytotoxicity is a point for further study. Here, it was demonstrated that F. philomiragia grown in host-adapted conditions (BHI, pH 6.8) is sensitive to levofloxacin but shows increased resistance to the human cathelicidin LL-37 and murine cathelicidin mCRAMP when compared to related the Francisella species, F. tularensis subsp. novicida and F. tularensis subsp. LVS. Previous findings that LL-37 is strongly upregulated in A549 cells following F. tularensis subsp. novicida infection suggest that the level of antimicrobial peptide expression is not sufficient in cells to eradicate the intracellular bacteria. Finally, this study demonstrates that F. philomiragia is lethal in two in vivo models; Galleria mellonella via hemocoel injection, with a LD50 of 1.8 × 10(3), and BALB/c mice by intranasal infection, with a LD50 of 3.45 × 10(3). In conclusion, F. philomiragia may be a useful model organism to study the genus Francisella, particularly for those researchers with interest in studying microbial ecology or environmental strains of Francisella. Additionally, the Biosafety level 2 status of F. philomiragia makes it an attractive model for virulence and pathogenesis studies.
Study Information
pubmed
2016
2016-05-24T00:00:00.000Z
10.3389/fmicb.2016.00696
24
72